Exponent, Inc. (EXPO) Tops Q3 EPS by 8c, Comments on Outlook
Get Alerts EXPO Hot Sheet
Price: $70.21 +1.20%
Financial Fact:
Total other income (expense), net: 2.33M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total other income (expense), net: 2.33M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Exponent, Inc. (NASDAQ: EXPO) reported Q3 EPS of $0.42, $0.08 better than the analyst estimate of $0.34. Revenue for the quarter came in at $77.6 million versus the consensus estimate of $74.46 million.
Business Outlook
“Based on our performance in the third quarter we are increasing our 2016 expectations, but remain cautious in the near-term due to softness in a few industry sectors,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer.
- Revenues before reimbursements are expected to be approximately flat for the year as compared to 2015.
- Underlying growth is expected to be in the low single digits, excluding the impact of the major project completion in the third quarter of 2015.
- 2016 EBITDA1 margin is expected to decline approximately 125 to 150 basis points as compared to 2015, as a result of lower utilization.
For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Vireo Growth completes acquisition of C21 Investments
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share